Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
38.46
-0.11 (-0.29%)
Jul 11, 2025, 1:41 PM - Market open
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.24 billion as of July 11, 2025. Its market cap has increased by 2.12% in one year.
Market Cap
2.24B
Enterprise Value
1.58B
1-Year Change
2.12%
Ranking
Category
Stock Price
$38.46
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.24B, an increase of 177.53%. That is a compound annual growth rate of 66.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 2.25B | -12.66% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |